600079 ST人福医药
2026/09 - 九个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额1,780,8682,518,7242,164,2651,967,2502,441,071
投资活动产生之现金流量净额753,879(390,372)(742,025)(1,224,718)1,226,790
筹资活动产生之现金流量净额(1,008,701)(1,801,100)(1,497,997)(2,105,567)(4,244,942)
汇率变动对现金及现金等价物的影响(76,540)(685)(23,867)16,29948,452
现金及现金等价物净增加/(减少)1,449,506326,567(99,624)(1,346,737)(528,629)
期初现金及现金等价物余额3,217,3872,890,8202,990,4454,337,1814,865,811
期末现金及现金等价物余额4,666,8933,217,3872,890,8202,990,4454,337,181